CAH - Cardinal Health, Inc.
46.58 0.00 (0.00%)
After hours: 4:18PM EDT
| Previous Close | 46.08 |
| Open | 46.13 |
| Bid | 46.58 x 800 |
| Ask | 46.59 x 800 |
| Day's Range | 45.94 - 46.89 |
| 52 Week Range | 42.17 - 66.45 |
| Volume | 3,212,199 |
| Avg. Volume | 3,254,711 |
| Market Cap | 13.882B |
| Beta (3Y Monthly) | 1.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings Date | May 9, 2019 |
| Forward Dividend & Yield | 1.91 (3.96%) |
| Ex-Dividend Date | 2019-03-29 |
| 1y Target Est | 54.00 |
Associated Press•12 hours agoIndictment: Ex-CEO ignored red flags as opioid crisis raged
NEW YORK (AP) — The pharmaceutical industry executive hit Tuesday with criminal charges stemming from the opioid crisis doesn't have his name on a museum wing, and his company isn't within earshot of Apple or anyone else on the Fortune 500. Even his $1.5 million paycheck was a paltry sum compared to his peers.
- Reuters•22 hours ago
U.S. brings first criminal case against major drug distributor over opioids
The U.S. government on Tuesday filed its first criminal charges against a major drug distributor and company executives over their alleged roles in fueling the nation's opioid epidemic by putting profits ahead of patients' safety. Rochester Drug Co-operative Inc (RDC), one of the 10 largest U.S. drug distributors, agreed to pay a $20 million fine and enter a five-year deferred prosecution agreement to resolve charges it turned a blind eye to thousands of suspicious orders for opioids. Two former RDC executives were also charged, including Laurence Doud, who had been its chief executive for more than 25 years.
- Zacks•yesterday
BioTelemetry (BEAT) to Report Q1 Earnings: What's in Store?
Products like MCT and Ware Holter are likely to aid BioTelemetry (BEAT) in Q1.
- Zacks•2 days ago
Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?
Strength in PerkinElmer's (PKI) core Diagnostics business is expected to drive Q1 results amid foreign exchange woes.
- Motley Fool•2 days ago
3 Dividend Stocks That Pay You More Than Pepsi Does
Looking for some stocks with higher yields than PepsiCo's 3%? Take a look at these three.
- Zacks•6 days ago
Thermo Fisher (TMO) to Report Q1 Earnings: What's in Store?
Strong analytical instruments business, product portfolio expansion and prudent growth strategy are likely to support Thermo Fisher (TMO) in Q1. However, forex might act as a dampener.
- Zacks•6 days ago
What's in Store for Align Technology (ALGN) in Q1 Earnings?
Higher Invisalign case volume, solid show by Clear Aligner segment and anticipated sturdy growth at Scanner and Service business are likely to support Align Technology (ALGN) in Q1. However, operating expenses are likely to act as dampeners.
- Zacks•6 days ago
Varian Medical (VAR) to Report Q2 Earnings: What's in Store?
Varian Medical (VAR) expects to gain significantly from APAC and EMEA regions in fiscal Q2.
- Zacks•7 days ago
What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?
Edwards Lifesciences (EW) expects to gain from core Critical Care product group in Q1.
- Zacks•8 days ago
UnitedHealth (UNH) Q1 Earnings Beat Estimates, Guides Up
UnitedHealth (UNH) Q1 earnings beat on higher revenues and membership.
- PR Newswire•9 days ago
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2019 on May 9
DUBLIN, Ohio , April 15, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2019 on May 9 prior to the opening of trading on the New York ...
- Zacks•12 days ago
Cardinal Health (CAH) Outpaces Stock Market Gains: What You Should Know
Cardinal Health (CAH) closed at $46.79 in the latest trading session, marking a +0.88% move from the prior day.
- Zacks•12 days ago
What's in the Store for UnitedHealth (UNH) Earnings in Q1?
UnitedHealth (UNH) should gain from higher revenues, membership partly offset by rise in expenses.
- Morningstar•14 days ago
Lowering Our Pharma Distributor Moat Ratings and Valuations
On the basis of the continued decline of pharmaceutical spending growth and external shock threats, we have lowered our economic moat ratings for AmerisourceBergen ABC , Cardinal Health CAH , and McKesson MCK to narrow from wide with a negative trend. The role of pharmaceutical distributor continues to evolve in an increasingly competitive and highly regulated environment. Scale and regulatory requirements have provided insulation to maintain share and generate market returns, but competitive pressures continue to build with declining reimbursement, healthcare consolidation, and decline in overall pharmaceutical spending growth.
- Zacks•20 days ago
Top Ranked Income Stocks to Buy for April 4th
Top Ranked Income Stocks to Buy for April 4th
- Zacks•22 days ago
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Insider Monkey•23 days ago
Here’s What Hedge Funds Think About Cardinal Health, Inc. (CAH)
Insider Monkey finished processing more than 700 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of December 31st, 2018. What do these smart investors think about Cardinal Health, Inc. (NYSE:CAH)? Cardinal Health, Inc. (NYSE:CAH) has seen an increase in support from the world's most elite money […]
Yahoo Finance•23 days agoDrug companies that benefit from the war on opioid addiction
The opioid crisis in the United States is a medical and societal tragedy, but some companies are working to fight addiction.
- Simply Wall St.•25 days ago
How Financially Strong Is Cardinal Health, Inc. (NYSE:CAH)?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Cardinal Health, Inc. (NYSE:CAH), a large-cap worth US$14b, comes to mind for investors seeking a strong and reliable stock i...
- Moody's•26 days ago
Owens & Minor Medical, Inc. -- Moody's downgrades Owens & Minor's CFR to B2; outlook is stable
Moody's Investors Service ("Moody's") downgraded Owens & Minor, Inc.'s Corporate Family Rating (CFR) to B2 from B1 and the Probability of Default Rating (PD) to B2-PD from B1-PD. Moody's also downgraded the ratings on the senior secured credit facilities and notes to B2 from B1. Concurrently, Moody's affirmed the SGL-3 Speculative Grade Liquidity Rating, signifying adequate liquidity.
Associated Press•27 days agoNew York sues billionaire family behind maker of OxyContin
NEW YORK (AP) — New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments seeking to hold not only the firm but its owners accountable for the nation's opioid crisis.
- Zacks•27 days ago
Can Retail Pharmacy USA Lift Walgreens' (WBA) Q2 Earnings?
Widening pharmacy network, healthy prescription volumes along with contributions from Rite Aid are expected to contribute to Walgreens Boots' (WBA) top line in the fiscal second quarter.
- Zacks•27 days ago
CAH or ALGN: Which Is the Better Value Stock Right Now?
CAH vs. ALGN: Which Stock Is the Better Value Option?
- TheStreet.com•27 days ago
McKesson or Cardinal Health: Which Is a Better Dividend Yield Buy?
Cardinal Health and McKesson Corporation have similar business models, but they are very different stocks. This is the case with McKesson and Cardinal Health, as well. McKesson is the more attractive stock for growth, while Cardinal Health is a high-yielding income stock.
- Zacks•last month
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
